Abstract |
In the last decades, a growing need to discover new compounds for the prevention and treatment of inflammatory diseases has led researchers to consider drugs derived from natural products as a valid option in the treatment of inflammation-associated disorders. The purpose of the present study was to investigate the anti-inflammatory effects of a new formulation of Moringa oleifera-derived 4-(α-L-rhamnopyranosyloxy)benzyl isothiocyanate as a complex with alpha-cyclodextrin (moringin + α-CD) on lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells, a common model used for inflammation studies. In buffered/aqueous solution, the moringin + α-CD complex has enhanced the water solubility and stability of this isothiocyanate by forming a stable inclusion system. Our results showed that moringin + α-CD inhibits the production of inflammatory mediators in LPS-stimulated macrophages by down-regulation of pro-inflammatory cytokines (TNF-α and IL-1β), by preventing IκB-α phosphorylation, translocation of the nuclear factor-κB (NF-κB), and also via the suppression of Akt and p38 phosphorylation. In addition, as a consequence of upstream inhibition of the inflammatory pathway following treatment with moringin + α-CD, the modulation of the oxidative stress (results focused on the expression of iNOS and nitrotyrosine) and apoptotic pathway (Bax and Bcl-2) was demonstrated. Therefore, moringin + α-CD appears to be a new relevant helpful tool to use in clinical practice for inflammation-associated disorders.
|
Authors | Sabrina Giacoppo, Thangavelu Soundara Rajan, Renato Iori, Patrick Rollin, Placido Bramanti, Emanuela Mazzon |
Journal | Inflammation research : official journal of the European Histamine Research Society ... [et al.]
(Inflamm Res)
Vol. 66
Issue 6
Pg. 487-503
(Jun 2017)
ISSN: 1420-908X [Electronic] Switzerland |
PMID | 28289752
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents
- IL1B protein, mouse
- Interleukin-1beta
- Isothiocyanates
- Lipopolysaccharides
- NF-kappa B
- Tumor Necrosis Factor-alpha
- alpha-Cyclodextrins
- moringin
- NF-KappaB Inhibitor alpha
- Proto-Oncogene Proteins c-akt
- p38 Mitogen-Activated Protein Kinases
- alpha-cyclodextrin
|
Topics |
- Animals
- Anti-Inflammatory Agents
(chemistry, pharmacology)
- Inflammation
(metabolism)
- Interleukin-1beta
(metabolism)
- Isothiocyanates
(chemistry, pharmacology)
- Lipopolysaccharides
- Mice
- Moringa
- NF-KappaB Inhibitor alpha
(metabolism)
- NF-kappa B
(metabolism)
- Proto-Oncogene Proteins c-akt
(antagonists & inhibitors)
- RAW 264.7 Cells
- Tumor Necrosis Factor-alpha
(metabolism)
- alpha-Cyclodextrins
(chemistry, pharmacology)
- p38 Mitogen-Activated Protein Kinases
(antagonists & inhibitors)
|